{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T14:48:25Z","timestamp":1787496505603,"version":"build-2736575974"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,3,25]],"date-time":"2021-03-25T00:00:00Z","timestamp":1616630400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,3,25]],"date-time":"2021-03-25T00:00:00Z","timestamp":1616630400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Divers"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1007\/s11030-021-10215-5","type":"journal-article","created":{"date-parts":[[2021,3,25]],"date-time":"2021-03-25T17:47:23Z","timestamp":1616694443000},"page":"279-292","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["In silico evaluation of potential inhibitory activity of remdesivir, favipiravir, ribavirin and galidesivir active forms on SARS-CoV-2 RNA polymerase"],"prefix":"10.1007","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8146-1663","authenticated-orcid":false,"given":"Ismail","family":"Celik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meryem","family":"Erol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zekeriya","family":"Duzgun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,25]]},"reference":[{"issue":"5","key":"10215_CR1","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.3390\/cells9051267","volume":"9","author":"M Romano","year":"2020","unstructured":"Romano M, Ruggiero A, Squeglia F, Maga G, Berisio R (2020) A Structural view of SARS-CoV-2 RNA replication machinery: RNA synthesis. Proofreading Final Cap Cells 9(5):1267. https:\/\/doi.org\/10.3390\/cells9051267","journal-title":"Proofreading Final Cap Cells"},{"issue":"1","key":"10215_CR2","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1080\/22221751.2020.1719902","volume":"9","author":"JF-W Chan","year":"2020","unstructured":"Chan JF-W, Kok K-H, Zhu Z, Chu H, ToYuan KK-WS, Yuen K-Y (2020) Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg Microbes Infect 9(1):221\u2013236. https:\/\/doi.org\/10.1080\/22221751.2020.1719902","journal-title":"Emerg Microbes Infect"},{"key":"10215_CR3","doi-asserted-by":"publisher","DOI":"10.1080\/07391102.2020.1781694","author":"VR Naik","year":"2020","unstructured":"Naik VR, Munikumar M, Ramakrishna U, Srujana M, Goudar G, Naresh P, KumarHemalatha BNR (2020) Remdesivir (GS-5734) as a therapeutic option of 2019-nCOV main protease\u2013in silico approach. J Biomol Struct Dyn. https:\/\/doi.org\/10.1080\/07391102.2020.1781694","journal-title":"J Biomol Struct Dyn"},{"issue":"1","key":"10215_CR4","doi-asserted-by":"publisher","first-page":"157","DOI":"10.23750\/abm.v91i1.9397","volume":"91","author":"D Cucinotta","year":"2020","unstructured":"Cucinotta D, Vanelli M (2020) WHO declares COVID-19 a pandemic. Acta Biomed Ateneo Parmense 91(1):157\u2013160. https:\/\/doi.org\/10.23750\/abm.v91i1.9397","journal-title":"Acta Biomed Ateneo Parmense"},{"key":"10215_CR5","unstructured":"Organization WHO (2020) Coronavirus disease 2019 (COVID-19): situation report, 82"},{"issue":"18","key":"10215_CR6","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","volume":"82","author":"W-j Guan","year":"2020","unstructured":"Guan W-j, Ni Z-y, Hu Y, Liang W-h, Ou C-q, He J-x, Liu L, ShanLei HC-l, Hui DS (2020) Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 82(18):1708\u20131720. https:\/\/doi.org\/10.1056\/NEJMoa2002032","journal-title":"N Engl J Med"},{"issue":"15","key":"10215_CR7","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1093\/cid\/ciaa272","volume":"71","author":"Z Wang","year":"2020","unstructured":"Wang Z, Yang B, Li Q, WenZhang LR (2020) Clinical features of 69 cases with coronavirus disease 2019 in Wuhan. China Clin Infect Dis 71(15):769\u2013777. https:\/\/doi.org\/10.1093\/cid\/ciaa272","journal-title":"China Clin Infect Dis"},{"issue":"10223","key":"10215_CR8","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/S0140-6736(20)30185-9","volume":"395","author":"C Wang","year":"2020","unstructured":"Wang C, Horby PW, HaydenGao FGGF (2020) A novel coronavirus outbreak of global health concern. Lancet 395(10223):470\u2013473. https:\/\/doi.org\/10.1016\/S0140-6736(20)30185-9","journal-title":"Lancet"},{"key":"10215_CR9","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","volume":"382","author":"W Guan","year":"2019","unstructured":"Guan W, Ni Z, Hu Y, Liang W, Ou C, He J, Liu L, Shan H, LeiHui CD (2019) Clinical characteristics of coronavirus disease. N Engl J Med 382:1708\u20131720. https:\/\/doi.org\/10.1056\/NEJMoa2002032","journal-title":"N Engl J Med"},{"key":"10215_CR10","volume-title":"Fenner and white's medical virology","author":"CJ Burrell","year":"2016","unstructured":"Burrell CJ, HowardMurphy CRFA (2016) Fenner and white\u2019s medical virology. Academic Press, London"},{"issue":"7798","key":"10215_CR11","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","volume":"579","author":"P Zhou","year":"2020","unstructured":"Zhou P, Yang X-L, Wang X-G, Hu B, Zhang L, Zhang W, Si H-R, Zhu Y, LiHuang BC-L (2020) A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579(7798):270\u2013273. https:\/\/doi.org\/10.1038\/s41586-020-2012-7","journal-title":"Nature"},{"issue":"3","key":"10215_CR12","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s11427-020-1637-5","volume":"63","author":"X Xu","year":"2020","unstructured":"Xu X, Chen P, Wang J, Feng J, Zhou H, Li X, ZhongHao WP (2020) Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission. Sci China Life Sci 63(3):457\u2013460. https:\/\/doi.org\/10.1007\/s11427-020-1637-5","journal-title":"Sci China Life Sci"},{"issue":"1","key":"10215_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/mSphere.00807-19","volume":"5","author":"B Li","year":"2020","unstructured":"Li B, Si H-R, Zhu Y, Yang X-L, Anderson DE, Shi Z-L, WangZhou L-FP (2020) Discovery of bat coronaviruses through surveillance and probe capture-based next-generation sequencing. Msphere 5(1):1\u201311. https:\/\/doi.org\/10.1128\/mSphere.00807-19","journal-title":"Msphere"},{"issue":"7807","key":"10215_CR14","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/s41586-020-2180-5","volume":"581","author":"J Lan","year":"2020","unstructured":"Lan J, Ge J, Yu J, Shan S, Zhou H, Fan S, Zhang Q, Shi X, Wang Q, Zhang L (2020) Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor. Nature 581(7807):215\u2013220. https:\/\/doi.org\/10.1038\/s41586-020-2180-5","journal-title":"Nature"},{"issue":"4","key":"10215_CR15","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1016\/j.cell.2020.03.045","volume":"181","author":"Q Wang","year":"2020","unstructured":"Wang Q, Zhang Y, Wu L, Niu S, Song C, Zhang Z, Lu G, Qiao C, Hu Y, Yuen K-Y (2020) Structural and functional basis of SARS-CoV-2 entry by using human ACE2. Cell 181(4):894\u2013904. https:\/\/doi.org\/10.1016\/j.cell.2020.03.045","journal-title":"Cell"},{"key":"10215_CR16","doi-asserted-by":"publisher","DOI":"10.1101\/2020.01.31.929042","author":"M Hoffmann","year":"2020","unstructured":"Hoffmann M, Kleine-Weber H, Kr\u00fcger N, Mueller MA, DrostenP\u00f6hlmann CS (2020) The novel coronavirus 2019 (2019-nCoV) uses the SARS-coronavirus receptor ACE2 and the cellular protease TMPRSS2 for entry into target cells. BioRxiv. https:\/\/doi.org\/10.1101\/2020.01.31.929042","journal-title":"BioRxiv"},{"issue":"4","key":"10215_CR17","doi-asserted-by":"publisher","first-page":"35","DOI":"10.4103\/ejop.ejop_61_20","volume":"22","author":"O Ayten","year":"2020","unstructured":"Ayten O, \u00d6zdemir C, Akt\u00fcrk \u00dcA, \u015een N (2020) Potential treatment of COVID-19. Eurasian J Pulmonol 22(4):35. https:\/\/doi.org\/10.4103\/ejop.ejop_61_20","journal-title":"Eurasian J Pulmonol"},{"issue":"4","key":"10215_CR18","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1172\/JCI138003","volume":"130","author":"A Casadevall","year":"2020","unstructured":"Casadevall A, Pirofski L-A (2020) The convalescent sera option for containing COVID-19. J Clin Invest 130(4):1545\u20131548. https:\/\/doi.org\/10.1172\/JCI138003","journal-title":"J Clin Invest"},{"issue":"7","key":"10215_CR19","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1002\/phar.2429","volume":"40","author":"SC Jorgensen","year":"2020","unstructured":"Jorgensen SC, Kebriaei R, Dresser LD (2020) Remdesivir: review of pharmacology, pre-clinical data and emerging clinical experience for COVID-19. Pharmacotherapy 40(7):659\u2013671. https:\/\/doi.org\/10.1002\/phar.2429","journal-title":"Pharmacotherapy"},{"issue":"4","key":"10215_CR20","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1021\/acsptsci.0c00076","volume":"3","author":"AJ Wiemer","year":"2020","unstructured":"Wiemer AJ (2020) Metabolic efficacy of phosphate prodrugs and the remdesivir paradigm. ACS Pharmacol Transl Sci 3(4):613\u2013626. https:\/\/doi.org\/10.1021\/acsptsci.0c00076","journal-title":"ACS Pharmacol Transl Sci"},{"issue":"11","key":"10215_CR21","doi-asserted-by":"publisher","first-page":"5202","DOI":"10.1128\/AAC.00649-13","volume":"57","author":"H Sangawa","year":"2013","unstructured":"Sangawa H, Komeno T, Nishikawa H, Yoshida A, Takahashi K, Nomura N, Furuta Y (2013) Mechanism of action of T-705 ribosyl triphosphate against influenza virus RNA polymerase. Antimicrob Agents Chemother 57(11):5202\u20135208. https:\/\/doi.org\/10.1128\/AAC.00649-13","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"10215_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/v12070705","volume":"12","author":"J Santos","year":"2020","unstructured":"Santos J, Brierley S, Gandhi MJ, Cohen MA, Moschella PC, Declan AB (2020) Repurposing therapeutics for potential treatment of SARS-CoV-2: a review. Viruses 12(7):1\u201319. https:\/\/doi.org\/10.3390\/v12070705","journal-title":"Viruses"},{"key":"10215_CR23","doi-asserted-by":"publisher","first-page":"4106","DOI":"10.1007\/s12035-020-02022-0","volume":"57","author":"R Kandimalla","year":"2020","unstructured":"Kandimalla R, John A, Abburi C, Vallamkondu J, Reddy PH (2020) Current status of multiple drug molecules, and vaccines: an update in SARS-CoV-2 therapeutics. Mol Neurobiol 57:4106\u20134116. https:\/\/doi.org\/10.1007\/s12035-020-02022-0","journal-title":"Mol Neurobiol"},{"key":"10215_CR24","doi-asserted-by":"publisher","first-page":"3215","DOI":"10.2147\/DDDT.S261154","volume":"14","author":"SM Hashemian","year":"2020","unstructured":"Hashemian SM, Farhadi T, Velayati AA (2020) A review on remdesivir: a possible promising agent for the treatment of COVID-19. Drug Des Devel Ther 14:3215\u20133222. https:\/\/doi.org\/10.2147\/DDDT.S261154","journal-title":"Drug Des Devel Ther"},{"issue":"1","key":"10215_CR25","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1002\/jmv.26264","volume":"93","author":"Y Wang","year":"2021","unstructured":"Wang Y, Anirudhan V, Du R, Cui Q, Rong L (2021) RNA-dependent RNA polymerase of SARS-CoV-2 as a therapeutic target. J Med Virol 93(1):300\u2013310. https:\/\/doi.org\/10.1002\/jmv.26264","journal-title":"J Med Virol"},{"key":"10215_CR26","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/j.ejmech.2016.10.061","volume":"127","author":"V Abet","year":"2017","unstructured":"Abet V, Filace F, Recio J, Alvarez-Builla J, Burgos C (2017) Prodrug approach: an overview of recent cases. Eur J Med Chem 127:810\u2013827. https:\/\/doi.org\/10.1016\/j.ejmech.2016.10.061","journal-title":"Eur J Med Chem"},{"issue":"1","key":"10215_CR27","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1289\/ehp.0900930","volume":"118","author":"GC Ghosh","year":"2010","unstructured":"Ghosh GC, Nakada N, Yamashita N, Tanaka H (2010) Oseltamivir carboxylate, the active metabolite of oseltamivir phosphate (Tamiflu), detected in sewage discharge and river water in Japan. Environ Health Perspect 118(1):103\u2013107. https:\/\/doi.org\/10.1289\/ehp.0900930","journal-title":"Environ Health Perspect"},{"issue":"9","key":"10215_CR28","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1021\/acs.bioconjchem.0c00323","volume":"31","author":"DS Chauhan","year":"2020","unstructured":"Chauhan DS, Prasad R, Srivastava R, Jaggi M, Chauhan SC, Yallapu MM (2020) Comprehensive review on current interventions, diagnostics, and nanotechnology perspectives against SARS-CoV-2. Bioconjug Chem 31(9):2021\u20132045. https:\/\/doi.org\/10.1021\/acs.bioconjchem.0c00323","journal-title":"Bioconjug Chem"},{"key":"10215_CR29","doi-asserted-by":"publisher","first-page":"100721","DOI":"10.1016\/j.drup.2020.100721","volume":"53","author":"A Artese","year":"2020","unstructured":"Artese A, Svicher V, Costa G, Salpini R, Di Maio VC, Alkhatib M, Ambrosio FA, Santoro MM, Assaraf YG, Alcaro S (2020) Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses. Drug Resist Updat 53:100721. https:\/\/doi.org\/10.1016\/j.drup.2020.100721","journal-title":"Drug Resist Updat"},{"key":"10215_CR30","first-page":"56","volume":"3","author":"K Sareen","year":"2020","unstructured":"Sareen K, Bose R, Singh R, Boddu L (2020) Treatment of COVID-19. Praxis Undergraduate Med Res J 3:56\u201364","journal-title":"Praxis Undergraduate Med Res J"},{"key":"10215_CR31","doi-asserted-by":"publisher","DOI":"10.1101\/2020.01.30.927574","author":"J Ju","year":"2020","unstructured":"Ju J, Kumar S, Li X, Jockusch S, Russo JJ (2020) Nucleotide analogues as inhibitors of viral polymerases. BioRxiv. https:\/\/doi.org\/10.1101\/2020.01.30.927574","journal-title":"BioRxiv"},{"issue":"6","key":"10215_CR32","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1016\/j.chempr.2020.04.023","volume":"6","author":"A D\u00f6mling","year":"2020","unstructured":"D\u00f6mling A, Gao L (2020) Chemistry and biology of SARS-CoV-2. Chem 6(6):1283\u20131295. https:\/\/doi.org\/10.1016\/j.chempr.2020.04.023","journal-title":"Chem"},{"key":"10215_CR33","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/d41573-020-00016-0","volume":"19","author":"LG De","year":"2020","unstructured":"De LG, Clercq E (2020) Therapeutic options for the 2019 novel coronavirus (2019-nCoV). Nat Rev Drug Discov 19:149\u2013150. https:\/\/doi.org\/10.1038\/d41573-020-00016-0","journal-title":"Nat Rev Drug Discov"},{"issue":"45","key":"10215_CR34","doi-asserted-by":"publisher","first-page":"26895","DOI":"10.1039\/D0RA05821A","volume":"10","author":"GE-DA Abuo-Rahma","year":"2020","unstructured":"Abuo-Rahma GE-DA, Mohamed MF, Ibrahim TS, Shoman ME, Abd SE, El-Baky RM (2020) Potential repurposed SARS-CoV-2 (COVID-19) infection drugs. RSC Adv 10(45):26895\u201326916. https:\/\/doi.org\/10.1039\/D0RA05821A","journal-title":"RSC Adv"},{"key":"10215_CR35","doi-asserted-by":"publisher","first-page":"104027","DOI":"10.1016\/j.bioorg.2020.104027","volume":"101","author":"MJ Akhtar","year":"2020","unstructured":"Akhtar MJ (2020) COVID19 inhibitors: a prospective therapeutics. Bioorg Chem 101:104027. https:\/\/doi.org\/10.1016\/j.bioorg.2020.104027","journal-title":"Bioorg Chem"},{"issue":"1","key":"10215_CR36","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1002\/jmv.26264","volume":"93","author":"Y Wang","year":"2020","unstructured":"Wang Y, Anirudhan V, Du R, Cui Q, Rong L (2020) RNA-dependent RNA polymerase of SARS-CoV-2 as a therapeutic target. J Med Virol 93(1):300\u2013310. https:\/\/doi.org\/10.1002\/jmv.26264","journal-title":"J Med Virol"},{"issue":"2","key":"10215_CR37","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1002\/cpt.1844","volume":"108","author":"YX Du","year":"2020","unstructured":"Du YX, Chen XP (2020) Favipiravir: pharmacokinetics and concerns about clinical trials for 2019-nCoV infection. Clin Pharm 108(2):242\u2013247. https:\/\/doi.org\/10.1002\/cpt.1844","journal-title":"Clin Pharm"},{"issue":"5","key":"10215_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/rmv.2136","volume":"30","author":"RA Giovane","year":"2020","unstructured":"Giovane RA, Rezai S, Cleland E, Henderson CE (2020) Current pharmacological modalities for management of novel coronavirus disease 2019 (COVID-19) and the rationale for their utilization: a review. Rev Med Virol 30(5):1\u20134. https:\/\/doi.org\/10.1002\/rmv.2136","journal-title":"Rev Med Virol"},{"issue":"11","key":"10215_CR39","doi-asserted-by":"publisher","first-page":"4690","DOI":"10.1021\/acs.jproteome.0c00392","volume":"19","author":"M Chien","year":"2020","unstructured":"Chien M, Anderson TK, Jockusch S, Tao C, Li X, Kumar S, Russo JJ, Kirchdoerfer RN, Ju J (2020) Nucleotide analogues as inhibitors of SARS-CoV-2 polymerase, a key drug target for COVID-19. J Proteome Res 19(11):4690\u20134697. https:\/\/doi.org\/10.1021\/acs.jproteome.0c00392","journal-title":"J Proteome Res"},{"issue":"5","key":"10215_CR40","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1021\/acscentsci.0c00489","volume":"6","author":"RT Eastman","year":"2020","unstructured":"Eastman RT, Roth JS, Brimacombe KR, Simeonov A, Shen M, Patnaik S, Hall MD (2020) Remdesivir: a review of its discovery and development leading to emergency use authorization for treatment of COVID-19. ACS Cent Sci 6(5):672\u2013683. https:\/\/doi.org\/10.1021\/acscentsci.0c00489","journal-title":"ACS Cent Sci"},{"issue":"6","key":"10215_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/pathogens9060426","volume":"9","author":"SN Neerukonda","year":"2020","unstructured":"Neerukonda SN, Katneni U (2020) A review on SARS-CoV-2 virology, pathophysiology, animal models, and anti-viral interventions. Pathogens 9(6):1\u201322. https:\/\/doi.org\/10.3390\/pathogens9060426","journal-title":"Pathogens"},{"issue":"24","key":"10215_CR42","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.1056\/NEJMoa2007016","volume":"382","author":"J Grein","year":"2020","unstructured":"Grein J, Ohmagari N, Shin D, Diaz G, Asperges E, Castagna A, Feldt T, Green G, GreenLescure MLF-X (2020) Compassionate use of remdesivir for patients with severe Covid-19. N Engl J Med 382(24):2327\u20132336. https:\/\/doi.org\/10.1056\/NEJMoa2007016","journal-title":"N Engl J Med"},{"key":"10215_CR43","doi-asserted-by":"publisher","first-page":"117592","DOI":"10.1016\/j.lfs.2020.117592","volume":"253","author":"AA Elfiky","year":"2020","unstructured":"Elfiky AA (2020) Ribavirin, remdesivir, sofosbuvir, galidesivir, and tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): a molecular docking study. Life Sci 253:117592. https:\/\/doi.org\/10.1016\/j.lfs.2020.117592","journal-title":"Life Sci"},{"key":"10215_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijbiomac.2020.05.184","volume":"160","author":"B Naik","year":"2020","unstructured":"Naik B, Gupta N, Ojha R, Singh S, PrajapatiPrusty VKD (2020) High throughput virtual screening reveals SARS-CoV-2 multi-target binding natural compounds to lead instant therapy for COVID-19 treatment. Int J Biol Macromol 160:1\u201317. https:\/\/doi.org\/10.1016\/j.ijbiomac.2020.05.184","journal-title":"Int J Biol Macromol"},{"key":"10215_CR45","doi-asserted-by":"publisher","DOI":"10.1080\/07391102.2020.1761882","author":"AA Elfiky","year":"2020","unstructured":"Elfiky AA (2020) SARS-CoV-2 RNA dependent RNA polymerase (RdRp) targeting: an in silico perspective. J Biomol Struct Dyn. https:\/\/doi.org\/10.1080\/07391102.2020.1761882","journal-title":"J Biomol Struct Dyn"},{"issue":"45","key":"10215_CR46","doi-asserted-by":"publisher","first-page":"26792","DOI":"10.1039\/D0RA04743K","volume":"10","author":"S Koulgi","year":"2020","unstructured":"Koulgi S, Jani V, Uppuladinne MV, SonavaneJoshi UR (2020) Remdesivir-bound and ligand-free simulations reveal the probable mechanism of inhibiting the RNA dependent RNA polymerase of severe acute respiratory syndrome coronavirus 2. RSC Adv 10(45):26792\u201326803. https:\/\/doi.org\/10.1039\/D0RA04743K","journal-title":"RSC Adv"},{"key":"10215_CR47","doi-asserted-by":"publisher","unstructured":"Kar P, Sharma NR, Singh B, Sen A, Roy A (2020) Natural compounds from Clerodendrum spp. as possible therapeutic candidates against SARS-CoV-2: An in silico investigation. J Biomol Struct Dyn. https:\/\/doi.org\/10.1080\/07391102.2020.1780947","DOI":"10.1080\/07391102.2020.1780947"},{"issue":"9","key":"10215_CR48","doi-asserted-by":"publisher","first-page":"7224","DOI":"10.1016\/j.arabjc.2020.08.004","volume":"13","author":"MA Alamri","year":"2020","unstructured":"Alamri MA, Altharawi A, Alabbas AB, AlossaimiAlqahtani MASM (2020) Structure-based virtual screening and molecular dynamics of phytochemicals derived from Saudi medicinal plants to identify potential COVID-19 therapeutics. Arab J Chem 13(9):7224\u20137234. https:\/\/doi.org\/10.1016\/j.arabjc.2020.08.004","journal-title":"Arab J Chem"},{"issue":"6498","key":"10215_CR49","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1126\/science.abc1560","volume":"368","author":"W Yin","year":"2020","unstructured":"Yin W, Mao C, Luan X, Shen D-D, Shen Q, Su H, Wang X, Zhou F, ZhaoGao WM (2020) Structural basis for inhibition of the RNA-dependent RNA polymerase from SARS-CoV-2 by remdesivir. Science 368(6498):1499\u20131504. https:\/\/doi.org\/10.1126\/science.abc1560","journal-title":"Science"},{"issue":"13","key":"10215_CR50","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/jcc.20084","volume":"25","author":"EF Pettersen","year":"2004","unstructured":"Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, MengFerrin ECTE (2004) UCSF Chimera\u2014a visualization system for exploratory research and analysis. J Comput Chem 25(13):1605\u20131612. https:\/\/doi.org\/10.1002\/jcc.20084","journal-title":"J Comput Chem"},{"key":"10215_CR51","doi-asserted-by":"publisher","unstructured":"Pradhan D, Priyadarshini V, Munikumar M, Swargam S, Umamaheswari A, Bitla A (2014) Para-(benzoyl)-phenylalanine as a potential inhibitor against LpxC of Leptospira spp.: homology modeling, docking, and molecular dynamics study. J Biomol Struct Dyn 32(2):171\u2013185. https:\/\/doi.org\/10.1080\/07391102.2012.758056","DOI":"10.1080\/07391102.2012.758056"},{"issue":"6","key":"10215_CR52","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1080\/07391102.2013.795871","volume":"32","author":"V Priyadarshini","year":"2014","unstructured":"Priyadarshini V, Pradhan D, Munikumar M, Swargam S, UmamaheswariRajasekhar AD (2014) Genome-based approaches to develop epitope-driven subunit vaccines against pathogens of infective endocarditis. J Biomol Struct Dyn 32(6):876\u2013889. https:\/\/doi.org\/10.1080\/07391102.2013.795871","journal-title":"J Biomol Struct Dyn"},{"key":"10215_CR53","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.jmgm.2018.04.002","volume":"82","author":"M Munikumar","year":"2018","unstructured":"Munikumar M, Krishna VS, Reddy VS, Rajeswari B, SriramRao DMV (2018) In silico design of small peptides antagonist against leptin receptor for the treatment of obesity and its associated immune-mediated diseases. J Mol Graph 82:20\u201336. https:\/\/doi.org\/10.1016\/j.jmgm.2018.04.002","journal-title":"J Mol Graph"},{"issue":"2","key":"10215_CR54","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1002\/wcms.1121","volume":"3","author":"R Salomon-Ferrer","year":"2013","unstructured":"Salomon-Ferrer R, CaseWalker DARC (2013) An overview of the Amber biomolecular simulation package. Wiley Interdiscip Rev Comput Mol Sci 3(2):198\u2013210. https:\/\/doi.org\/10.1002\/wcms.1121","journal-title":"Wiley Interdiscip Rev Comput Mol Sci"},{"issue":"1","key":"10215_CR55","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1186\/1756-0500-5-367","volume":"5","author":"AWS Da Silva","year":"2012","unstructured":"Da Silva AWS, Vranken WF (2012) ACPYPE-Antechamber python parser interface. BMC Res Notes 5(1):367. https:\/\/doi.org\/10.1186\/1756-0500-5-367","journal-title":"BMC Res Notes"},{"key":"10215_CR56","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","volume":"1\u20132","author":"MJ Abraham","year":"2015","unstructured":"Abraham MJ, Murtola T, Schulz R, P\u00e1ll S, Smith JC, HessLindahl BE (2015) GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX 1\u20132:19\u201325. https:\/\/doi.org\/10.1016\/j.softx.2015.06.001","journal-title":"SoftwareX"},{"issue":"8","key":"10215_CR57","doi-asserted-by":"publisher","first-page":"1950","DOI":"10.1002\/prot.22711","volume":"78","author":"K Lindorff-Larsen","year":"2010","unstructured":"Lindorff-Larsen K, Piana S, Palmo K, Maragakis P, Klepeis JL, DrorShaw RODE (2010) Improved side-chain torsion potentials for the Amber ff99SB protein force field. Proteins 78(8):1950\u20131958. https:\/\/doi.org\/10.1002\/prot.22711","journal-title":"Proteins"},{"key":"10215_CR58","doi-asserted-by":"publisher","unstructured":"Zhang L, Zhou R (2020) Binding mechanism of remdesivir to SARS-CoV-2 RNA dependent RNA polymerase. Preprints 1\u201318. https:\/\/doi.org\/10.20944\/preprints202003.0267.v1","DOI":"10.20944\/preprints202003.0267.v1"}],"container-title":["Molecular Diversity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-021-10215-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11030-021-10215-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-021-10215-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,28]],"date-time":"2022-02-28T13:40:14Z","timestamp":1646055614000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11030-021-10215-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,25]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["10215"],"URL":"https:\/\/doi.org\/10.1007\/s11030-021-10215-5","relation":{},"ISSN":["1381-1991","1573-501X"],"issn-type":[{"value":"1381-1991","type":"print"},{"value":"1573-501X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,25]]},"assertion":[{"value":"30 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}